Carbohydrate chains in cancer are crucial biomarkers, as abnormal glycosylation patterns are often associated with tumor progression and metastasis. These chains influence cell adhesion, signaling, and immune evasion, making them key targets for diagnosis and therapy. Understanding their role enables the development of innovative diagnostic tools and therapeutic strategies, advancing precision medicine in oncology.